ProfileGDS4718 / 226322_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 63% 94% 55% 63% 41% 48% 49% 66% 61% 58% 65% 39% 51% 47% 65% 64% 60% 36% 60% 63% 69% 60% 67% 60% 49% 68% 35% 62% 44% 41% 75% 54% 40% 57% 51% 43% 75% 50% 95% 64% 37% 73% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4220564
GSM549102patient 115, normal, homogenized [OPG study]6.3587863
GSM549104patient 119, normal, homogenized [OPG study]10.140494
GSM549108patient 138, normal, homogenized [OPG study]5.8299755
GSM549119patient 077, normal, homogenized [OPG study]6.2993263
GSM549133patient 032, cancer, homogenized [OPG study]4.9692941
GSM549139patient 042, cancer, homogenized [OPG study]5.4005948
GSM549099patient 107, normal, homogenized [OPG study]5.4664749
GSM549109patient 139, normal, homogenized [OPG study]6.5267766
GSM549110patient 046, normal, homogenized [OPG study]6.18761
GSM549114patient 063, normal, homogenized [OPG study]5.919458
GSM549122patient 082, normal, homogenized [OPG study]6.5091765
GSM549134patient 033, cancer, homogenized [OPG study]4.9427639
GSM549136patient 036, cancer, homogenized [OPG study]5.5252151
GSM549140patient 044, cancer, homogenized [OPG study]5.2883447
GSM549111patient 047, normal, homogenized [OPG study]6.5090665
GSM549113patient 057, normal, homogenized [OPG study]6.4212564
GSM549132patient 031, cancer, homogenized [OPG study]6.1481260
GSM549137patient 038, cancer, homogenized [OPG study]4.777636
GSM549142patient 047, cancer, homogenized [OPG study]6.2294960
GSM549100patient 110, normal, homogenized [OPG study]6.3386363
GSM549107patient 135, normal, homogenized [OPG study]6.7923769
GSM549115patient 068, normal, homogenized [OPG study]6.1057960
GSM549116patient 072, normal, homogenized [OPG study]6.6201267
GSM549120patient 078, normal, homogenized [OPG study]6.1548760
GSM549131patient 030, cancer, homogenized [OPG study]5.421249
GSM549118patient 074, normal, homogenized [OPG study]6.7395468
GSM549129patient 027, cancer, homogenized [OPG study]4.7827635
GSM549123patient 088, normal, homogenized [OPG study]6.2950862
GSM549124patient 006, cancer, homogenized [OPG study]5.2333844
GSM549126patient 015, cancer, homogenized [OPG study]5.0276741
GSM549128patient 025, cancer, homogenized [OPG study]7.3906675
GSM549103patient 117, normal, homogenized [OPG study]5.7589954
GSM549117patient 073, normal, homogenized [OPG study]4.9456940
GSM549138patient 041, cancer, homogenized [OPG study]5.9353857
GSM549141patient 045, cancer, homogenized [OPG study]5.5255551
GSM549130patient 028, cancer, homogenized [OPG study]5.1243643
GSM549101patient 111, normal, homogenized [OPG study]7.3045275
GSM549105patient 128, normal, homogenized [OPG study]5.5278850
GSM549106patient 134, normal, homogenized [OPG study]10.487995
GSM549112patient 048, normal, homogenized [OPG study]6.3608364
GSM549125patient 011, cancer, homogenized [OPG study]4.8516237
GSM549127patient 024, cancer, homogenized [OPG study]7.257473
GSM549135patient 035, cancer, homogenized [OPG study]5.5605151